A Double Blind, Randomized 3rd Party Open, Placebo Controlled, Parallel Group Multiple Oral Escalating Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of UK-396,082 In Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 27 Jul 2010
At a glance
- Drugs UK 396082 (Primary)
- Indications Thrombosis
- Focus Adverse reactions
- 27 Jul 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Apr 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 27 Mar 2010 New trial record